Assessment and management of gastroesophageal reflux disease following bariatric surgery.
Daniel Davis D.O.
King, K., R. Sudan, S. Bardaro, I. Soriano, A. T. Petrick, S. C. Daly, E. Lo Menzo, D. Davis, A. Leyva-Alvizo, M. Gonzalez-Urquijo, D. Eisenberg and M. El Chaar (2021). “Assessment and management of gastroesophageal reflux disease following bariatric surgery.” Surg Obes Relat Dis 17(11): 1919-1925.
Gastroesophageal reflux disease (GERD) is a common disease in patients with obesity. The incidence of de novo GERD and the effect of bariatric surgery on patients with pre-existing GERD remain controversial. Management of GERD following bariatric surgery is complicated and can range from medical therapy to non-invasive endoscopic options to invasive surgical options. To address these issues, we performed a systematic review of the literature on the incidence of GERD and the various modalities of managing GERD in patients following bariatric surgery. Given the increased number of laparoscopic sleeve gastrectomy (LSG) procedures being performed and the high incidence of GERD following LSG, bariatric surgeons should be familiar with the options available to manage GERD following LSG as well as other bariatric procedures.